• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    7.08 Down 0.03(0.42%) Apr 17, 4:00PM EDT
    |After Hours : 7.12 Up 0.04 (0.56%) Apr 17, 6:27PM EDT
    Add to Portfolio
    Prev Close:7.11
    Open:7.03
    Bid:6.94 x 3100
    Ask:7.18 x 1200
    1y Target Est:9.25
    Beta:2.98
    Next Earnings Date:11-May-15ARWR Earnings announcement
    Day's Range:6.84 - 7.12
    52wk Range:4.95 - 17.42
    Volume:1,456,117
    Avg Vol (3m):1,727,760
    Market Cap:387.93M
    P/E (ttm):N/A
    EPS (ttm):-1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARWRDown 0.42%387.93M
    PENCUp 1.02%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,289.97
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.47
    Quarterly EPS Est (Mar-15) :-0.34
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):-0.66

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback